Skip to main content
Find more clinical trials

APOE, Metabolism, and Cognitive Function

Start: April 24, 2018
End: January 30, 2020
Enrollment: 75

What Is This Study About?

This study aims to better understand the relationship between variations of the APOE gene and metabolism by testing metabolic rate at rest and during a cognitive challenge in healthy adults. Results may help investigators identify new targets for the prevention and treatment of cognitive decline and dementia.

Do I Qualify To Participate in This Study?

Minimum Age: 18 Years

Maximum Age: 65 Years

Must have:

  • Cognitively normal
  • Good health

Must NOT have:

  • Pregnant or breastfeeding
  • Current bleeding disorder
  • History of stroke, seizures, Parkinson's disease, head injury with loss of consciousness, or other dementing disorder
  • History of alcoholism or drug abuse
  • History of schizophrenia or current bipolar disorder or major depression
  • Vision or hearing loss that could interfere with cognitive testing

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Lance Johnson

Source: ClinicalTrials.gov ID: NCT03109561